Sonoporation and Chemotherapy for the Treatment of Pancreatic Cancer
Phase 1
Recruiting
- Conditions
- Locally Advanced Pancreatic Ductal AdenocarcinomaMetastatic Pancreatic Ductal AdenocarcinomaStage II Pancreatic Cancer AJCC v8Stage IIA Pancreatic Cancer AJCC v8Stage IIB Pancreatic Cancer AJCC v8Stage III Pancreatic Cancer AJCC v8Stage IV Pancreatic Cancer AJCC v8Unresectable Pancreatic Ductal Adenocarcinoma
- Interventions
- Other: Perflubutane MicrobubbleProcedure: Contrast-Enhanced UltrasoundOther: Quality-of-Life AssessmentProcedure: Computed TomographyProcedure: Magnetic Resonance Imaging
- First Posted Date
- 2021-03-29
- Last Posted Date
- 2025-04-22
- Lead Sponsor
- Flemming Forsberg
- Target Recruit Count
- 120
- Registration Number
- NCT04821284
- Locations
- 🇳🇴
Haukeland University Hospital, Bergen, Norway
🇺🇸Sidney Kimmel Cancer Center at Thomas Jefferson University, Philadelphia, Pennsylvania, United States
© Copyright 2025. All Rights Reserved by MedPath